Why HCQ and Ivermectin were removed from India’s Covid-19 treatment protocol

The Indian Council of Medical Research (ICMR) and the National Task Force on Covid-19 have dropped the use of Ivermectin and Hydroxychloroquine (HCQ) drugs from their revised guidelines for the treatment of the infection.

The decision was taken after experts found that these drugs have little to no effect on Covid-related mortality or clinical recovery of the patient.

“HCQ may be considered for removal from guideline, with recommendation to use with caution only in clinical trial setting (since there is some genuine uncertainty regarding the possible benefit for severe cases and in low dose),” said the document titled ‘considerations for exclusion of Ivermectin and Hydroxychloroquine from the clinical guidance for management of adult Covid-19 patients’.

Several clinical studies have shown the low mortality benefit for HCQ, said the document. In fact, when HCQ is administered with azithromycin, it increases the risk of adverse drug effect (ADE) in patients, experts said.

ALSO READ | India reports 29,616 new Covid-19 cases in 24 hours, recovery rate highest since March 2020

Studies also found there was no clarity on mortality benefit, no effect on length of hospital stay and recovery in case of Ivermectin.

Recommending that Ivermectin be dropped from the clinical guidance, experts cited 13 systematic reviews of which “7/13 showed mortality benefit, 4/13 no mortality benefit, 2/13 inconclusive/unclear.”

Additionally, there was a high risk of bias in many of the studies, particularly with the ones showing mortality benefit, as the level of certainty is low in them.

The recommendations were made at a meeting of the All India Institute of Medical Sciences (AIIMS) and the ICMR national task force for Covid-19 and the Joint Monitoring Group on August 20.

ALSO READ | Covid-19: Maharashtra govt tells medical oxygen manufacturers to maintain stock at 95% capacity

Meanwhile, cautioning that the upcoming festival season is a critical period, AIIMS-Delhi Director Dr Randeep Guleria said the next 6-8 weeks are going to be critical and the community has to come together to ensure people follow all Covid norms and aggressively encourage vaccination.

While the number of new Covid-19 cases are steadily declining across the country, the Union Health Ministry has advised states and UTs to keep a strict vigil as the country is still in the midst of the second surge of the pandemic.

WATCH | 67% Indians have developed Covid-19 antibodies: Fourth sero survey

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
ADHA to upgrade My Health Record maintenance thumbnail

ADHA to upgrade My Health Record maintenance

The Australian Digital Health Agency has started exploring new solutions to upgrade the maintenance of the national digital health record system.  It recently issued a request for information about available "technical or process-driven advances and/or innovative service solutions" to better support, maintain, and enhance its digital health applications, including My Health Record (MHR), ensuring they
Read More
Smartphones under Rs 25,000 to buy in festive sale thumbnail

Smartphones under Rs 25,000 to buy in festive sale

The festive sale on e-commerce sites Amazon– The Great Indian Festival sale and the Big Billion Days sale on Flipkart is now live. Users can get big discounts on smartphones priced under Rs 25,000 and enjoy savings through various offers, exchange bonuses, and reduced prices.IQOO Z7 Pro The iQOO Z7 Pro is a sub-Rs 25,000 gaming
Read More
ACP, ATA, ORCHA announce new framework supporting health app safety thumbnail

ACP, ATA, ORCHA announce new framework supporting health app safety

The American College of Physicians, the American Telemedicine Association and the Organization for the Review of Care and Health Applications announced a new framework this week aimed at helping healthcare professionals and patients make informed decisions about digital health tools.   The Digital Health Assessment Framework will help analyze technologies including mobile apps and web-based…
Read More
Index Of News